Permethrin-treated Baby-wraps for the Prevention of Malaria in Children (NCT05391230) | Clinical Trial Compass
CompletedNot Applicable
Permethrin-treated Baby-wraps for the Prevention of Malaria in Children
Uganda400 participantsStarted 2022-06-03
Plain-language summary
The scientific objective of this study is to test the protective effect of permethrin-treated lesus against P. falciparum malaria in infants and young children.
Who can participate
Age range6 Months – 99 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Provide signed and dated informed consent form (ICF)
* Willing to comply with all study procedures and be available for the duration of the study
* Female of any age with a child 6 to 18 months of age at the time of enrollment
* Resident of village located in Bugoye, Maliba, or Mubuku sub-counties. Recruitment will initially focus on residents of villages within 2 km of study clinics in order to facilitate attendance, but we will not restrict enrollment to residents of these villages.
Exclusion Criteria:
* Mother or child taking any malaria chemoprevention regimen, including individuals living with HIV or exposed children who are taking cotrimoxazole that may modify risk of malaria
* Child with known sickle cell disease
* Known allergic reactions to components of the study product(s)
* Treatment with another investigational drug or other intervention
* Anything that would place the individual at increased risk or preclude the individual's full compliance with or completion of the study.